PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2011 2012 2013 2014 2015 2016
With carried over funding from FY10, SCMS will continue to provide technical assistance to LifeGap project's decentralized procurement system to supply OI drugs to PEPFAR and non-PEPFAR supported sites upon PEPFAR's request.
SCMS will use $200,000 to continue procuring Amphotericin B on to PEPFAR sites.
SCMS will use $100,000 as Emergency OI Procurement Fund to fill in interruption of OI supply in case LifeGap project fails to supply OI drugs in a timely manner to PEPFAR-supported sites.
SCMS will use $200,000 to procure therapeutic foods for HIV adult and pediatric patients: There is currently no therapeutic or supplementary feeding for PLHIV in clinical care in Vietnam. Based on the result of RUTF acceptability study and SAM/MAM prevalence study, AED/FANTA-2 will provide technical assistance to PEPFAR/Vietnam to identify appropriate therapeutic and supplementary food products and calculate the amounts needed to meet energy requirement of malnourished adults and children living with HIV.
As part of the PEPFAR program and in support of the uninterrupted treatment and care of those living with HIV/AIDS in Vietnam, SCMS will continue to fund and improve quantification, procurement, storage and distribution of HIV related medicines, lab supplies and other commodities supported through PEPFAR.
Building on the activities started in FY2010 in ARVs in FY 2011 SCMS activities will focus on transfer of capacity to PAC or other appropriate Government staff to manage dispensers and stock managers at the site level. SCMS will work closely with the VAAC in ensuring the appropriate staff is identified; that they are aware that this is their mandate and that the appropriate training and mentoring is provided.
? Continue to support the provision of ARV drugs to PEPFAR-supported out-patient clinics and other non-PEPFAR supported sites depending upon PEPFAR's programming with Vietnam Administration for AIDS Control (VAAC).
? To sustain the ARV supply chain in Vietnam and build capacity for PAC staff, plan join site visits with PAC staff to transfer knowledge and skills in the areas of ARV dispensing and counseling, verifying stock, stock conditions and expiry dates and general problem solving.
? Train PAC staff to use self learning curriculum for new dispensers developed in FY10 so that PACs can provide effective coaching and site supervision.
? In support of the Government of Vietnam's HIV/AIDS National Strategy, SCMS will assist the Government of Vietnam to design and implement a long-term strategy for developing a more efficient, effective national supply chain system for the distribution of HIV related medicines, lab supplies and commodities.
? Focus on health systems strengthening through supporting the Government of Vietnam's new initiative to develop a single National Distribution System for ARVs and other HIV/AIDS commodities that will be managed by the VAAC and PACs. By merging the three existing ARV supply chains into a single national system under the management of the VAAC the sustainability of distribution of these life saving drugs will be increased.
? Building on the activities started in FY2010 in ARVs in FY 2011 SCMS activities will focus on transfer of capacity to PAC or other appropriate Government staff to manage dispensers and stock managers at the site level in the areas of Methadone and Laboratory. SCMS will work closely with the VAAC in ensuring the appropriate staff is identified; that they are aware that this is their mandate and that the appropriate training and mentoring is provided.
? Support the MOH's development of needed Circulars and Decrees in order to provide the legal authority to implement a National Distribution System.
? Work with the GVN to implement a paper based LMIS.
? Institute national forecasting and procurement planning for ARVs on a quarterly basis.
? Support the NTP to develop a distribution strategy and planning for MDR drugs at a national level.
Provide safe, secure, timely, and cost-effective delivery of methadone from their point of origin to the final client destination. Out of this total, $2,000,000 will be used for methadone procurement.
Provide in-country commodity strategic planning coordination to improve commodity availability, transparency, data-driven decision making and resource management by all organizations and institutions.
Support the Government of Vietnam to develop sustainable narcotics supply chain management to meet the requirement of methadone program scale up.
- Continue to support the provision of ARV drugs for PMTCT ARV prophylaxis to PEPFAR-supported sites and other non-PEPFAR supported sites depending upon PEPFAR's programming with Vietnam Administration for AIDS Control (VAAC).
- To sustain the ARV supply chain in Vietnam and build capacity for PAC staff, plan join site visits with PAC staff to transfer knowledge and skills in the areas of ARV dispensing and counseling, verifying stock, stock conditions and expiry dates and general problem solving.
-Train PAC staff to use self learning curriculum for new dispensers developed in FY10 so that PACs can provide effective coaching and site supervision.
? Support HIV laboratories by procuring and delivering best-value, appropriate-quality CD4 reagents in a timely manner to 20 laboratory sites including 13 BD machines and 7 Cyflow machines.
? Support CD4 testing for approximately 17,000 pre-ART patients and 48,000 ART patients supported by PEPFAR and 19,300 pre-ART and 4,700 ART patients in Global Fund-supported and National Program-supported sites.
? Provide hands-on technical assistance to supported laboratories by paying regular visits. It is required that PEPFAR will transition out of Global Fund-supported sites, so Global Fund project's lab staff need to accompany SCMS staff in order to learn and take over SCMS work after three years.
? SCMS will provide a cost-effective in-country and international procurement service to support PEPFAR supply chain in delivering best-value, appropriate- quality products in timely manner that avoids stock-outs of vital ARV drugs.
